Drug wholesaler McKesson sued for drug price fixing

One of the leading pharmaceutical distribution firms in the U.S., McKesson Corp., has just been sued by a class of consumers who feel the company overinflated the average wholesale price of certain drugs in order to set payments in stone handed out to insured patients and Medicaid recipients.

In other words, the company used a "price fixing" scheme to artificially set prices that insurers had to pay -- hence, those insured patients had little choice than to pay the requested amount form their insurance company.

I'm not sure how this customer group can prove that the average wholesale price was artificially boosted, but I'll be watching this case with interest. If you're a Medicaid subscriber or an insured person with prescription drug coverage, perhaps you should also.